//
sign in
Post
by @danabra.mov
PostEmbed
by @danabra.mov
Record
by @jimpick.com
Record
by @atsui.org
+ new component
Post
Pα+ Psychedelic Bulletin #217: - Gilgamesh’s GM-1020 Prints Positive Topline - FDA Lifts Hold on GH Research’s 5-MeO-DMT IND - Compass Details Pivotal PTSD Trial Design - Cybin Becomes Helus - much more... psychedelicalpha.com/news/p%ce%b1...
5mo
Gilgamesh Prints Positive Topline from Phase 2a Study of NMDA Receptor Agonist for MDD • FDA Lifts Hold on GH Research’s Inhaled 5-MeO-DMT IND After More than Two Years • Cybin Rebrands to Helus…
psychedelicalpha.com
Pα+ Psychedelic Bulletin #217: Gilgamesh’s GM-1020 Prints Positive Topline; FDA Lifts Hold on GH Research’s 5-MeO-DMT IND; Compass Details Pivotal PTSD Trial Design; Cybin Becomes Helus - Psychedelic ...
josh hardman